References
- ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002CA Cancer J Clin20055527410815761078
- CrewKDNeugutAIEpidemiology of gastric cancerWorld J Gastroenterol200612335436216489633
- ArakAKullKFactors influencing survival of patients after radical surgery for gastric cancer. A regional study of 406 patients over a 10-year periodAnn Oncol1994338913920
- CunninghamDAllumWHStenningSPPerioperative chemotherapy versus surgery alone for respectable gastroesophageal cancerN Engl J Med20063551112016822992
- SikoraKPersonalized cancer therapy-the key to the futurePharmacogenomics20045422522815102537
- WangXYanSKDaiWXLiuXRZhangWDWangJJA metabolomics approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancerInt J Cancer2010127122841285021351263
- BangYJvan CutsemEFeyereislovaATrastuzumab in combination with chemotheraphy versus chemotheraphy alone for treatment of Her2-positive advanced gastric or gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trailLancet2010376974268769720728210
- HynesNEInghamPWLimWAMarshallCJMassaguéJPawsonTSignalling change: signal transduction through the decadesNat Rev Mol Cell Biol201314639339823636498
- CidonEUEllisSGInamYAdelekeSZarifSGeldartTMolecular targeted agents for gastric cancer: a step forward towards personalized therapyCancers201351649124216699
- GarciaFVizosoAMartinLClinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancerAnn Surg Oncol200310323424112679307
- HayashiMInokuchiMTakagiYHigh expression of HER3 is associated with a decreased survival in gastric cancerClin Cancer Res200814237843784919047113
- BurgessAWChoHSEigenbrotCAn open-and-shut case? Recent insights into the activation of EGF/ErbB receptorsMol Cell200312354155214527402
- RiquelmeISaavedraKEspinozaJAMolecular classification of gastric cancer: towards a pathway-driven targeted therapyOncotarget2015628247502477926267324
- QiFLiAInagakiYChinese herbal medicines as adjuvant treatment during chemo-or radio-therapy for cancerBiosci Trends20104629730721248427
- KasettiRBNabiSASwapnaSApparaoCCinnamic acid as one of the antidiabetic active principle(s) from the seeds of Syzygium alternifoliumFood Chem Toxicol20125051425143122342809
- DeviSAnsariSAVadiveluJMégraudFTenguriaSAhmedNHelicobacter pylori antigen HP0986 (TieA) interacts with cultured gastric epithelial cells and induces IL8 secretion via NF-κB mediated pathwayHelicobacter2014191263624205801
- BaiYZhaoFLiYWangLFangXJWangCYGinkgo biloba extract induce cell apoptosis and G0/G1 cycle arrest in gastric cancer cellsInt J Clin Exp Med2015811209772098226885028
- MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation cytotoxicity assaysJ Immunol Methods1983651–255636606682
- PozarowskiPDarzynkiewiczZAnalysis of cell cycle by flow cytometryMethods Mol Biol200428130131115220539
- MOE. 2011Molecular Operating Environment 2011.10Chemical Computing Group IncMontreal, QC, Canada
- LabutePThe generalized born/volume integral (GB/VI) implicit solvent model: estimation of free energy of hydration using London dispersion instead of atomic surface areaJ Comput Chem200829101693169818307169
- YangSPharmacophore modeling and applications in drug discovery: challenges and recent advancesDrug Discov Today20101511–1244445020362693
- BerendsenHJCvan der SpoelDvan DrunenRGROMACS: a message-passing parallel molecular dynamics implementationComput Phys Commun1995911–34356
- Lindorff-LarsenKPianaSPalmoKImproved side-chain torsion potentials for the Amber ff99SB protein force fieldProteins20107881950195820408171
- SchüttelkopfAWvan AaltenDMFPRODRG: a tool for high-throughput crystallography of protein-ligand complexesActa Crystallogr D Biol Crystallogr200460Pt 81355136315272157
- BerendsenHJCGrigeraJRStraatsmaTPThe missing term in effective pair potentialsJ Phys Chem1987912462696271
- BerendsenHJCPostmaJPMVan GunsterenWFDinolaAHaakJRMolecular dynamics with coupling to an external bathJ Chem Phys198481836843690
- ParrinelloMRahmanAPolymorphic transitions in single crystals: a new molecular dynamics methodJ Appl Phys1981521271827190
- LipinskiCALomdardoFDominyBWFeeneeyPJExperimental and computational approaches to estimate solubility and permeability in drug discovery and development settingAdv Drug Deliv Rev1997231–3325
- AertgeertsKSkeneRYanoJStructural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 proteinJ Biol Chem201128621187561876521454582
- SaliABlundellTLComparative protein modeling by satisfaction of spatial restraintsJ Mol Biol199323437798158254673
- KabschWSanderCDictionary of protein secondary structure pattern recognition hydrogen-bonded geometrical lecturesBiopolymers19832212257726376667333
- LobanowMBogatyrevNSGalzitskaiaOVRadius of gyration is an indicator of compactness of protein structureMol Biol (Mosk)200842470170618856071
- DurhamEDorrBWoetzelNStaritzbichlerRMeilerJSolvent accessible surface area approximations for rapid and accurate protein structure predictionJ Mol Model20091591093110819234730
- IshikawaTSetoMBannoHDesign and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo [3,2-d] pyrimidine scaffoldJ Med Chem201154238030805022003817